2BB score and signals
Inhibikase Therapeutics, Inc.’s current 2BB score is 32 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 35 | Low |
| Momentum | 67 | Improving |
| Financial strength | 27 | Weak |
| Quality | 60 | Strong |
| Risk | 46 | Moderate |
Company facts
| Headquarters | Wilmington, Delaware, United States |
| Founded | 2008 |
| Employees | 35 |
| 52-week range | $1.33 – $2.53 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-12 | — | -0.1128 | — | $0.00 |
| 2026-08-12 | — | -0.1081 | — | $0.00 |
| 2026-05-12 | -0.1 | -0.1094 | $0.00 | $0.00 |
| 2026-03-26 | -0.09 | -0.1042 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish